Tags

Type your tag names separated by a space and hit enter

Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
Fed Regist. 2002 Feb 08; 67(27):5942-3.FR

Abstract

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. This final rule is part of FDA's ongoing review of OTC drug products.

Authors

No affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

11837282

Citation

Food and Drug Administration, HHS. "Topical Antifungal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule." Federal Register, vol. 67, no. 27, 2002, pp. 5942-3.
Food and Drug Administration, HHS. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule. Fed Regist. 2002;67(27):5942-3.
Food and Drug Administration, HHS. (2002). Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule. Federal Register, 67(27), 5942-3.
Food and Drug Administration, HHS. Topical Antifungal Drug Products for Over-the-counter Human Use; Amendment of Final Monograph. Final Rule. Fed Regist. 2002 Feb 8;67(27):5942-3. PubMed PMID: 11837282.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule. A1 - ,, PY - 2002/2/12/pubmed PY - 2002/2/28/medline PY - 2002/2/12/entrez SP - 5942 EP - 3 JF - Federal register JO - Fed Regist VL - 67 IS - 27 N2 - The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph for over-the-counter (OTC) topical antifungal drug products to add the ingredient clotrimazole as generally recognized as safe and effective for the treatment of athlete's foot, jock itch, and ringworm. This final rule is part of FDA's ongoing review of OTC drug products. SN - 0097-6326 UR - https://www.unboundmedicine.com/medline/citation/11837282/Topical_antifungal_drug_products_for_over_the_counter_human_use L2 - http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=2002_register&docid=02-3079-filed.pdf DB - PRIME DP - Unbound Medicine ER -